You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

BioMarin Pharmaceutical drug succeeds in clinical trial

Continue reading below

BioMarin Pharmaceutical Inc. said an experimental treatment for Morquio A Syndrome, a rare genetic disease, succeeded in a clinical trial. The disease causes systemic skeletal dysplasia, short stature, and joint abnormalities, which limit mobility and endurance.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week